Drug Safety Associate at Startup
High Conscientiousness and Emotional Stability to process ICSRs, meet expedited reporting deadlines, and maintain the pharmacovigilance database.
In pharma startups, time to regulatory approval defines survival
Intellectual property and patents are strategic assets from day one
Partnerships with academic institutions accelerate development with less capital
Ideal OCEAN+ Profile
At startups (1-50 employees), ability to interpret complex cases, identify emerging signals, and adapt processes to new ICH E2 guidelines and local regulations
At startups (1-50 employees), precision in documenting adverse events, meeting expedited deadlines (7/15 days), and maintaining the pharmacovigilance database
At startups (1-50 employees), communication with physicians and reporters to obtain additional case information; internal presentations of safety metrics
At startups (1-50 employees), collaboration with medical, regulatory, and legal teams to evaluate and manage complex safety cases
At startups (1-50 employees), tolerance for peak case volumes, pressure from regulatory deadlines, and the distressing nature of serious adverse event report content
At startups (1-50 employees), the pharmacovigilance associate operates under regulatory reporting deadlines for adverse events (15 days for SUSARs, 7 days for fatal cases) and defined case-handling processes; adherence to case processing pace is non-negotiable
Strengths and Red Flags
Strengths
- Accurate, on-time processing of ICSRs within expedited regulatory deadlines
- Maintaining the quality and consistency of the safety database
- Agile navigation of the regulatory process for new molecules or devices with a small team
- Managing strategic partnerships with research institutions and laboratories
Red Flags
- Case processing errors that cause expedited reports to miss deadlines
- Inconsistent MedDRA term coding that compromises signal detection
- Underestimates the time and cost of the regulatory process
- Prioritizes development speed over rigor in GMP documentation
Interview Questions
How many cases do you process on average per month? What is your expedited deadline compliance rate, and how do you handle volume spikes?
Evaluates: Conscientiousness and management of high-precision operational workload
Describe your process for coding MedDRA terms on a case with multiple adverse events. What criteria do you use to select the most appropriate term?
Evaluates: Conscientiousness and technical rigor in safety processing
How did you navigate the regulatory process for your first molecule/device with a small team?
Evaluates: Conscientiousness and regulatory pragmatism
How did you prioritize with a limited development pipeline and capital?
Evaluates: Strategic decision-making ability under severe constraints
More about Drug Safety Associate
Career path, personality archetypes and similar roles in the full profile.
This Role in Other Contexts
Drug Safety Associate — base profile with no company context
View profile → SMB (51-200 employees)In SMB pharma, quality and compliance are the license to operate
View profile → Enterprise (201-1000 employees)In enterprise pharma, multi-market regulatory complexity is the norm
View profile → Global (1001+ employees)Global pharma means registrations in dozens of markets with different requirements
View profile →Does your next Drug Safety Associate at Startup (1-50 employees) match this profile?
Map anyone's OCEAN+ profile with the Talent Diagnostic: free, no signup, 10 minutes.
20 statements · 10 minutes · no card